StockData
Cigna Group logo

Cigna Group (CI) stock analysis

CINYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3021% below fair value
$301.45−1.68 (-0.55%)

Close on Nov 11, 2026Market cap $79.66BP/E 13.3Yield 2.00%

StockData Score

Prices as of Nov 11, 2026How the score works

Value6Growth2Performance3Health2Dividend3

Solid16 of 30 checks passed

Cigna passes 16 of the 30 checks behind our score; 6 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
6/6
Growth
2/6
Past performance
3/6
Financial health
2/6
Dividend
3/6

What stands out

  • Margin of safety over 20%

    The price is 21.5% below fair value, more than the 20% cushion we look for.

  • Trading below fair value

    The share price of $301.45 is below our fair value estimate of $383.88.

  • Revenue growing 10%+ a year

    Revenue grew 15.0% a year over the last three fiscal years.

  • Interest well covered

    Operating income covers interest expense 7.1 times.

What to watch

  • High debt

    Debt is 71.8% of shareholders' equity, above the 40% we consider low.

  • EPS growing under 10% a year

    Diluted EPS grew 1.2% a year over the last three fiscal years.

  • Growing slower than the industry

    Revenue grew 6.8% over the last twelve months; the Accident and Health Insurance and Medical median is 6.8%.

  • Gross margin slipping

    Gross margin was 20.7% over the last twelve months, against 23.1% a year earlier.

Valuation6/6
  • P/E below its 5-year median

    Cigna's P/E of 13.3 is below its own 5-year median of 15.6.

  • P/E below the industry

    Cigna's P/E of 13.3 is below the Accident and Health Insurance and Medical median of 21.3.

  • P/S below the industry

    Cigna's price-to-sales of 0.28 is below the Accident and Health Insurance and Medical median of 0.80.

  • P/B below the industry

    Cigna's price-to-book of 1.84 is below the Accident and Health Insurance and Medical median of 2.31.

  • Trading below fair value

    The share price of $301.45 is below our fair value estimate of $383.88.

  • Margin of safety over 20%

    The price is 21.5% below fair value, more than the 20% cushion we look for.

Growth2/6
  • Revenue growing 10%+ a year

    Revenue grew 15.0% a year over the last three fiscal years.

  • EPS growing under 10% a year

    Diluted EPS grew 1.2% a year over the last three fiscal years.

  • Earnings acceleration

    Needs positive net income now, a year ago and five years ago.

  • Growing slower than the industry

    Revenue grew 6.8% over the last twelve months; the Accident and Health Insurance and Medical median is 6.8%.

  • Guidance raised

    Cigna raised its Full Year Ending December 31, 2026 Cigna Healthcare Medical Care Ratio outlook on Jul 30, 2026.

  • Gross margin slipping

    Gross margin was 20.7% over the last twelve months, against 23.1% a year earlier.

Past performance3/6
  • Return on equity

    Needs positive equity and five years of results.

  • Return on assets over 1%

    Return on assets was 3.8%; for a bank or insurer, 1% or more is considered good.

  • Return on equity above the industry

    Cigna's return on equity of 14.1% is above the Accident and Health Insurance and Medical median of 11.9%.

  • Earnings over 5 years

    Needs positive net income five years ago and in the latest year.

  • Net margin against its history

    Needs five years of revenue and net income.

  • Net margin above the industry

    Cigna's net margin of 2.1% is above the Accident and Health Insurance and Medical median of 2.0%.

Financial health2/6
  • High debt

    Debt is 71.8% of shareholders' equity, above the 40% we consider low.

  • Debt rising against equity

    Debt to equity rose from 65.4% five years ago to 71.8%.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 30.3% of total debt.

  • Interest well covered

    Operating income covers interest expense 7.1 times.

  • Short-term assets don't cover short-term debts

    Current assets are 0.84 times current liabilities.

  • Bankruptcy risk (Altman Z)

    The Altman model does not apply to insurers.

Dividend3/6
  • Pays a dividend

    Cigna paid dividends worth 2.1% of the share price over the last twelve months.

  • Yield below Treasuries

    The 2.1% yield is below the 4.4% on a 1-year Treasury.

  • Yield below the top quarter

    The top quarter of US dividend payers yield 3.8% or more; Cigna yields 2.1%.

  • Dividend not cut

    The dividend per share has not fallen by more than 10% in any of the last 9 fiscal years.

  • Covered by earnings

    Dividends take 27.2% of net income.

  • Cash-flow cover

    Needs dividends paid and free cash flow.

Scores of similar companies

Our estimate per share

$383.88

The share price is 21% below this estimate.

20%+ below
Near fair value
20%+ above
$301.45Price$383.88Fair value
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
P/E18.5×15.6×21.3×$418.4650%
P/B2.1×2.0×2.3×$349.3050%
Fair value$383.88100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 15.6
  • Accident and Health Insurance and Medical median 21.3

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Low risk

Average value traded per day
$475.99M
Value traded per 1% price move
$348.37M

Downside

Low risk

Typical loss in a bad month
9.4%
Volatility (annualized)
27%
Sharpe ratio, 1 year
0.46
Beta to the S&P 500 (5Y)
0.34

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2015 to 2025

Gross margin

21.8%−13.7 pts over 5 years

Operating margin

3.3%−1.7 pts over 5 years

Net margin

2.2%

See a number that looks wrong?